Why Axonics Modulation Technologies Stock Is Soaring Today
Shares of Axonics Modulation Technologies (NASDAQ: AXNX), a medical device company focused on bladder and bowel dysfunction, rose 15% as of 11:00 a.m. EST on Thursday. The double-digit jump is a response to the news that the company won FDA approval for its Axonics r-SNM (rechargeable sacral neuromodulation) System.
The FDA granted premarket approval for the Axonics r-SNM System as a treatment for urinary urge incontinence, urinary urge frequency, as well as urinary retention (OAB).
Image source: Getty Images.
Source Fool.com
